Sugi Predict

Sugi Predict / Compounds / SCHEMBL779893

SCHEMBL779893

SCHEMBL779893

CCC(C)OC(=O)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.43
▸ FAAH O00519 1/20 0.36
▸ TSHR P16473 4/20 0.33
▸ CHRM2 P08172 2/20 0.33
▸ CHRM4 P08173 2/20 0.33
▸ CHRM1 P11229 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ TBXA2R P21731 1/20 0.33
▸ LMNA P02545 4/20 0.32
▸ CHRM5 P08912 1/20 0.32
▸ CHRM3 P20309 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ GALR3 O60755 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2980611 1.00 MAPT (0.43) MAPTFAAHTSHRCHRM2CHRM4
SCHEMBL1216964 1.00 MAPT (0.43) MAPTFAAHTSHRCHRM2CHRM4
Magnesium SCHEMBL29456102 0.97 MAPT (0.42) MAPTFAAHTSHRCHRM2CHRM4
SCHEMBL14989440 0.85 MAPT (0.41) MAPTFAAHTSHRCHRM2CHRM4
SCHEMBL14989441 0.85 MAPT (0.41) MAPTFAAHTSHRCHRM2CHRM4
SCHEMBL14887474 0.85 MAPT (0.41) MAPTFAAHTSHRCHRM2CHRM4
SCHEMBL14887223 0.85 MAPT (0.41) MAPTFAAHTSHRCHRM2CHRM4
SCHEMBL15574890 0.85 MAPT (0.41) MAPTFAAHTSHRCHRM2CHRM4
SCHEMBL14887353 0.85 MAPT (0.41) MAPTFAAHTSHRCHRM2CHRM4
SCHEMBL11878704 0.85 MAPT (0.41) MAPTFAAHTSHRCHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110981873-B Preparation method for synthesizing pyrroloquinoline quinone by five-step method 江西农业大学 2025-01-24 — — CN claimed
CN-117460706-A Recovered component oxo product 伊士曼化工公司 2024-01-26 — — CN claimed
US-9427777-B2 Process for producing charge retention medium ASAHI GLASS COMPANY, LIMITED (JP) 2016-08-30 — — US claimed
EP-2125702-A1 LEVODOPA DIMETHYL-SUBSTITUTED DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE Xenoport, Inc. (US) 2009-12-02 — — EP claimed
WO-2008076458-A1 LEVODOPA DIMETHYL-SUBSTITUTED DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE XENOPORT, INC. (US) 2008-06-26 — — WO claimed
CN-119422872-A Propagation and application of new apple germplasm obtained through grafting hybridization 山东农业大学 2025-02-14 — — CN disclosed
CN-110981873-B Preparation method for synthesizing pyrroloquinoline quinone by five-step method 江西农业大学 2025-01-24 — — CN disclosed
CN-119156438-A Perfume composition for sleep improvement 国际香料和香精公司 2024-12-17 — — CN disclosed
WO-2024213709-A1 COMPOSITIONS FOR LITHIUM-ION BATTERY ELECTRODES, ELECTRODES AND BATTERIES USING SAID COMPOSITIONS ARKEMA FRANCE (FR) 2024-10-17 — — WO disclosed
EP-4447148-A1 COMPOSITIONS FOR LITHIUM-ION BATTERY ELECTRODES, ELECTRODES AND BATTERIES USING SAID COMPOSITIONS ARKEMA FRANCE (FR) 2024-10-16 — — EP disclosed
EP-4318629-A1 PRIMER FOR POWER STORAGE DEVICE ELECTRODES, COMPOSITION FOR FORMING PRIMER LAYER, ELECTRODE FOR POWER STORAGE DEVICES, AND SECONDARY BATTERY AGC INC. (JP) 2024-02-07 — — EP disclosed
CN-117460706-A Recovered component oxo product 伊士曼化工公司 2024-01-26 — — CN disclosed
US-7342016-B2 Farnesyl protein transferase inhibitors as antitumor agents SCHERING CORPORATION (US) 2008-03-11 — — US disclosed
US-20070244221-A1 Solubilizer and Composition Containing Same KUREHA CORPORATION (JP) 2007-10-18 — — US disclosed
US-20070167473-A1 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. 2007-07-19 — — US disclosed
US-20070123606-A1 Phase change inks containing curable amide gellant compounds XEROX CORPORATION 2007-05-31 — — US disclosed
US-20070078150-A1 Substituted pyrindinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2007-04-05 — — US disclosed
US-20070078150-A1 Substituted pyrindinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2007-04-05 — — US disclosed
US-6667285-B1 Branched-chain carboxylic acid monoalkyl ester with outstanding hydrolytic stability NEW JAPAN CHEMICAL CO., LTD. (JP) 2003-12-23 — — US disclosed
EP-1225213-A1 LUBRICATING OIL FOR REFRIGERATOR, HYDRAULIC FLUID COMPOSITION FOR REFRIGERATOR AND METHOD FOR LUBRICATION OF REFRIGERATOR NEW JAPAN CHEMICAL CO.,LTD. (JP) 2002-07-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078150-A1 Substituted pyrindinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto PC, GPR119, PNPO MAPT 4243/4885FAAH 949/4885TSHR 1805/4885
US-20070167473-A1 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto PLPBP, PNPO, PDXK MAPT 3480/4885FAAH 1439/4885TSHR 1399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.